Heredia, Lima, Per´U Tulane University, LA, USA Nikolaos Vasilakis University of Texas Medical Branch, TX, USA Gissella Vasquez U.S

Heredia, Lima, Per´U Tulane University, LA, USA Nikolaos Vasilakis University of Texas Medical Branch, TX, USA Gissella Vasquez U.S

Executive Organizing Committee Mariana Legu´ıa(Chair) Pontificia Universidad Cat´olicadel Per´u,Lima, Per´u Carlos Sariol (Secretary) University of Puerto Rico, PR, USA Mark Challberg National Institutes of Health, MD, USA George Dimopoulos Johns Hopkins University, MD, USA Andrea Gamarnik Fundaci´onInstituto Leloir, Buenos Aires, Argentina Eva Harris University of California-Berkeley, CA, USA Amy C. Morrison University of California-Davis, CA, USA Mauricio L. Nogueira Faculdade de Medicina de S~aoJos´edo Rio Preto, Brazil Valerie Paz-Sold´an Universidad Peruana Cayetano Heredia, Lima, Per´u Tulane University, LA, USA Nikolaos Vasilakis University of Texas Medical Branch, TX, USA Gissella Vasquez U.S. Naval Medical Research Unit No. 6, Lima, Per´u Daniela Weiskopf La Jolla Institute for Immunology, CA, USA Peruvian Organizing Committee Mariana Legu´ıa(Chair) Directora, Laboratorio de Gen´omica Pontificia Universidad Cat´olicadel Per´u Vilma R. Bejar Directora, Instituto de Medicina Tropical Daniel A. Carri´on Universidad Nacional Mayor de San Marcos C´esar Cabezas Jefe, Instituto Nacional de Salud Profesor, Universidad Nacional Mayor de San Marcos M´aximoM. Espinoza Presidente, Sociedad Peruana de Enfermedades Infecciosas y Tropicales Theresa J. Ochoa Directora, Instituto de Medicina Tropical Alexander von Humboldt Universidad Peruana Cayetano Heredia Valerie Paz-Sold´an Profesora, Universidad Peruana Cayetano Heredia Profesora, Tulane University Gissella V´asquez Sub Jefa, Departamento de Entomolog´ıa U.S. Naval Medical Research Unit No. 6 Hans D. V´asquez Ex Jefe, Instituto Nacional de Salud Scientific Committee Andrea Gamarnik (Chair) Fundaci´onInstituto Leloir, Buenos Aires, Argentina Eva Harris (Co-Chair) University of California-Berkeley, CA, USA Sub-Committees Virology/Pathogenesis/Antivirals Diagnostics/Prognostics/Clinical Andrea Gamarik (Chair) Jorge Mu~noz(Chair) Rosa Mar´ıadel Angel´ (Co-Chair) Luisa Alvarado (Co-Chair) Andrea da Pollan Patricia Brasil Elsa Damonte Paquita Garc´ıa Mauro Teixeira Susan Wong Epi/Phylogenetics/Modeling/ Vector Biology/Ecology/Control Burden Amy C. Morrison (Chair) Albert Ko (Chair) George Dimopolous (Co-Chair) Mauricio L. Nogueira (Co-Chair) Roberto Barrera Nate Grubaugh Luciano Moreira Mariana Legu´ıa Nikos Vasilakis Isabel Rodriguez Gissella V´asquez Diana Rojas Tyler Sharp Immunology/Vaccines Eva Harris (Chair) Human Behavior & Community Ana Sesma (Co-Chair) Engagement Aravinda de Silva Josefina Coloma (Chair) Daniela Weiskopf Valerie Paz-Sold´an(Co-Chair) Steve Whitehead Table of Contents Oral Presentations...................................1 Diagnostics-Prognostics-Clinical.......................1 Epi-Phylogenetics-Modeling-Burden.................4 Human Behavior & Community Engagement....7 Immunology-Vaccines.......................................9 Vector Biology-Ecology-Control.......................13 Virology-Pathogenesis-Antivirals......................16 Highlighted Posters.................................21 Diagnostics-Prognostics-Clinical.......................21 Epi-Phylogenetics-Modeling-Burden.................24 Human Behavior & Community Engagement...27 Immunology-Vaccines......................................28 Vector Biology-Ecology-Control.......................30 Virology-Pathogenesis-Antivirals......................32 Posters....................................................36 Diagnostics-Prognostics-Clinical.......................36 Epi-Phylogenetics-Modeling-Burden.................69 Human Behavior & Community Engagement....91 Immunology-Vaccines.......................................94 Vector Biology-Ecology-Control......................110 Virology-Pathogenesis-Antivirals.....................124 Late Breaker Abstracts...........................146 Author Index..........................................165 Oral Presentations Diagnostics-Prognostics- nificantly higher ratio of plasma ZIKV/DENV1-4 Clinical NS1 IgG than mothers without suspected ZIKV infection and IgG-ZIKV was higher in mothers that their children. When mothers and progeny 1 were match, the levels of anti-NS1-ZIKV IgG was significantly higher in those that developed CZS High and specific Humoral maternal- that mothers exposed to ZIKV but children with- and-child response to NS1 correlates out CZS. We propose a transplacental movement with long-term neurological effects of ZIKV NS1-IgG to explain the correlation found during prenatal Zika virus exposure in virus-specific IgG between mothers and chil- dren. Levels of ZIKV NS1-IgG were transient Doris M. Salgado1,2, Jos´e S. Cort´es1, William as they fall to undetectable in children older 6 Mej´ıa1,2, Roc´ıo Vega1,2, Angela Ort´ız1,2, Irene months. Neurological follow-up was done in 104 Bosch3,4, Isabel DeLaura1,5, Lee Gehrke6,7, Car- infants, including 17 patients with microcephaly, los F. Narv´aez1,2 10 with ocular abnormalities and 77 children with- 1Divisi´onde Inmunolog´ıa y Pediatr´ıa, Programa de out CZS. 16% of the children prenatally exposed Medicina, Facultad de Salud, Universidad Surcolom- to ZIKV without CZS presented other cognitive biana, Neiva, Huila, Colombia; 2Servicio de Pediatr´ıa, compromise, 15% motor and 6% of the language Hospital Universitario de Neiva, Neiva, Huila, Colom- impairment. Thus, ZIKV prenatal infections in- bia; 3E25Bio Inc., The Engine of MIT, MA, USA; duced a virus-specific humoral response with po- 4Department of Medicine, Mount Sinai School of tential trans-placenta movement and correlated in Medicine, NY, USA; 5School of Medicine, Duke Uni- magnitude with infection. Additionally, prenatal versity, Durham, NC, USA; 6Massachusetts Institute infection of ZIKV results in a high frequency of of Technology, Cambridge, MA, USA; 7Department of cognitive disorders that are uncover upon neuro- Microbiology, Harvard Medical School, Boston, MA, logical follow-up. USA Humoral responses play a critical role in the pro- 2 tection and pathogenesis of the Zika virus (ZIKV) infection and its congenital consequences. To Clinical and epidemiological charac- determine the pre-exposure to ZIKV in high-risk terization of orthobunyavirus associ- populations such as pregnant women and children ated with febrile disease in humans in through their virus-specific antibody response is the Peruvian Amazon crucial. Due to the high number of asymptomatic 1 1 infections and cross-reactive responses among co- Crystyan Siles , Stalin Vilcarromero , Helvio 1 2 1,3 circulating Flaviviruses, screening for prior expo- Astete , Carlos Alvarez , Amy C. Morrison , 1 1 sure is a challenge. Here, we analyzed the circulat- Carolina Guevara , Eugenio Abente , Julia S. Am- 1 ing ZIKV and dengue virus (DENV)-specific IgG, puero and the neurodevelopment in 104 symptomatic 1U.S. Naval Medical Research Unit No.6, Iquitos and mothers admitted to the Hospital Universitario Lima, Per´u; 2Direcci´onRegional de Salud, Loreto, de Neiva, Colombia and the progeny exposed to Per´u; 3University of California, Davis, CA, USA ZIKV in utero, during the epidemic year. There Introduction: Emerging infectious diseases can were 17 newborns diagnosed with congenital zika negatively impact medical readiness of the US mil- syndrome (CZS) in this cohort. A NS1-based in- itary and continued surveillance is warranted to direct ELISA was used to evaluate levels of ZIKV support Force Health Protection. Viruses from and DENV-specific IgG. A 12 months neurologi- the genus Orthobunyavirus circulate globally in cal follow-up including the specific Bayley III scale tropical, temperate and arctic ecological niches evaluating the motor, language, and cognitive as- and include Oropouche (OROV) Guaroa (GROV) pects, was applied to all children. The ZIKV and viruses from the group C serogroup (GRCV). IgG NS1-based ELISA shows a low cross-reactivity Objectives: To characterize the clinical and epi- with DENV when samples of children with con- demiological aspects of orthobunyaviruses associ- firmed primary or secondary DENV infection were ated with febrile disease in humans. Methods: tested. Mothers with ZIKV infections shown a sig- Subjects no less than 5 years old with fever no 1 less than 5 days in duration who sought medi- y Referencia, Ministry of Health, Managua, Nicaragua cal attention in urban, peri-urban and rural health 5Department of Epidemiology, School of Public facilities in Iquitos, Peru were invited to partici- Health, University of Michigan, Ann Arbor, MI, USA pate in an IRB-approved clinic-based surveillance 6Centro de Salud S´ocratesFlores Vivas, Ministry of study. Acute and convalescent blood sample were Health, Managua, Nicaragua collected. Samples were screened for evidence Introduction. While Zika in adults presents as a of viral infection by RT-PCR and/or viral isola- mild, dengue-like disease, pediatric Zika remains tion and/or a 4-fold increase in IgM antibodies an understudied topic. The World Health Orga- as tested by ELISA in paired samples. Results: nization (WHO) and Pan American Health Orga- 2448/8395 samples collected between December nization (PAHO) Zika case definitions have not 2010 and May 2016 were positive for an arbovirus: been assessed in children. Objective.We aimed flaviviruses (n=2308), alphaviruses (n=94) and to characterize clinical profiles and evaluate the orthobunyaviruses (n=46). Among the orthobun- diagnostic performance of the WHO and PAHO yaviruses found, 20 were GROV, 17 were GRCV case definitions in a large cohort of pediatric Zika and 9 were OROV. Of the 46 positive-cases for an cases. Materials and methods. We prospectively orthobunyavirus, 50% were

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    182 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us